192 related articles for article (PubMed ID: 22718526)
1. The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients.
Wesmiller SW; Henker RA; Sereika SM; Donovan HS; Meng L; Gruen GS; Tarkin IS; Conley YP
Biol Res Nurs; 2013 Oct; 15(4):382-9. PubMed ID: 22718526
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of Postoperative Nausea and Vomiting.
Aroke EN; Hicks TL
J Perianesth Nurs; 2019 Dec; 34(6):1088-1105. PubMed ID: 31227296
[TBL] [Abstract][Full Text] [Related]
3. CYP2D6 basic genotyping as a potential tool to improve the antiemetic efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting.
Niewiński PA; Wojciechowski R; Śliwiński M; Hurkacz ME; Głowacka K; Orzechowska-Juzwenko K; Wiela-Hojeńska AK
Adv Clin Exp Med; 2018 Nov; 27(11):1499-1503. PubMed ID: 30058787
[TBL] [Abstract][Full Text] [Related]
4. The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?
Candiotti KA; Birnbach DJ; Lubarsky DA; Nhuch F; Kamat A; Koch WH; Nikoloff M; Wu L; Andrews D
Anesthesiology; 2005 Mar; 102(3):543-9. PubMed ID: 15731591
[TBL] [Abstract][Full Text] [Related]
5. Pediatric CYP2D6 metabolizer status and post-tonsillectomy nausea and vomiting after ondansetron.
Black K; Brenn BR; Gaedigk A; Wanderer JP; Van Driest SL
Clin Transl Sci; 2023 Feb; 16(2):269-278. PubMed ID: 36350309
[TBL] [Abstract][Full Text] [Related]
6. Prevention of postoperative nausea and vomiting with granisetron and dolasetron in relation to CYP2D6 genotype.
Janicki PK; Schuler HG; Jarzembowski TM; Rossi M
Anesth Analg; 2006 Apr; 102(4):1127-33. PubMed ID: 16551910
[TBL] [Abstract][Full Text] [Related]
7. A history of severe nausea and vomiting during pregnancy predicts a higher incidence of postoperative nausea and vomiting after breast cancer surgery without breast reconstruction.
Wang B; Yan T; Sun L; Zhang G; Zheng H
Breast Cancer; 2021 Mar; 28(2):506-512. PubMed ID: 33242108
[TBL] [Abstract][Full Text] [Related]
8. Genetic Factors Associated with Postoperative Nausea and Vomiting: a Systematic Review.
López-Morales P; Flores-Funes D; Sánchez-Migallón EG; Lirón-Ruiz RJ; Aguayo-Albasini JL
J Gastrointest Surg; 2018 Sep; 22(9):1645-1651. PubMed ID: 29725907
[TBL] [Abstract][Full Text] [Related]
9. Postoperative nausea and vomiting: The role of the dopamine D2 receptor TaqIA polymorphism.
Frey UH; Schnee C; Achilles M; Silvanus MT; Esser J; Peters J
Eur J Anaesthesiol; 2016 Feb; 33(2):84-9. PubMed ID: 26225495
[TBL] [Abstract][Full Text] [Related]
10. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G
Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374
[TBL] [Abstract][Full Text] [Related]
11. Exploring the multifactorial nature of postoperative nausea and vomiting in women following surgery for breast cancer.
Wesmiller SW; Sereika SM; Bender CM; Bovbjerg D; Ahrendt G; Bonaventura M; Conley YP
Auton Neurosci; 2017 Jan; 202():102-107. PubMed ID: 27729204
[TBL] [Abstract][Full Text] [Related]
12. CYP2D6 poor metabolizer genotype and smoking predict severe postoperative pain in female patients on arrival to the recovery room.
Yang Z; Yang Z; Arheart KL; Morris R; Zhang Y; Rodriguez Y; Song C; Gitlin MC; Candiotti KA
Pain Med; 2012 Apr; 13(4):604-9. PubMed ID: 22497725
[TBL] [Abstract][Full Text] [Related]
13. [Postoperative nausea and vomiting (PONV). Clinical significance, basic principles, prevention and therapy].
Simanski C; Waldvogel HH; Neugebauer E
Chirurg; 2001 Dec; 72(12):1417-26. PubMed ID: 11824026
[TBL] [Abstract][Full Text] [Related]
14. Role of CYP2D6 Polymorphisms in the Outcome of Postoperative Pain Treatment.
Seripa D; Latina P; Fontana A; Gravina C; Lattanzi M; Savino M; Gallo AP; Melchionda G; Santini SA; Margaglione M; Copetti M; di Mauro L; Panza F; Greco A; Pilotto A
Pain Med; 2015 Oct; 16(10):2012-23. PubMed ID: 25989235
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
Zhou SF
Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Ramosetron and Palonosetron for Preventing Nausea and Vomiting after Spinal Surgery: Association With ABCB1 Polymorphisms.
Song JW; Shim JK; Choi SH; Soh S; Jang J; Kwak YL
J Neurosurg Anesthesiol; 2017 Oct; 29(4):406-414. PubMed ID: 27564555
[TBL] [Abstract][Full Text] [Related]
17. CHRM3 rs2165870 polymorphism is independently associated with postoperative nausea and vomiting, but combined prophylaxis is effective.
Klenke S; de Vries GJ; Schiefer L; Seyffert N; Bachmann HS; Peters J; Frey UH
Br J Anaesth; 2018 Jul; 121(1):58-65. PubMed ID: 29935595
[TBL] [Abstract][Full Text] [Related]
18. A serotonin transporter polymorphism is associated with postoperative nausea and vomiting: An observational study in two different patient cohorts.
Stamer UM; Schmutz M; Wen T; Banz V; Lippuner C; Zhang L; Steffens M; Stüber F
Eur J Anaesthesiol; 2019 Aug; 36(8):566-574. PubMed ID: 31274544
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors and frequency of postoperative nausea and vomiting in patients operated under general anesthesia].
Grabowska-Gaweł A; Porzych K; Piskunowicz G
Przegl Lek; 2006; 63(2):72-6. PubMed ID: 16969906
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D2 receptor Taq IA polymorphism is associated with postoperative nausea and vomiting.
Nakagawa M; Kuri M; Kambara N; Tanigami H; Tanaka H; Kishi Y; Hamajima N
J Anesth; 2008; 22(4):397-403. PubMed ID: 19011779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
